Safety and Immunogenicity Study of the Hepatitis B Vaccine, HEPLISAV™, Compared to Engerix-B® Vaccine
Clinical trial NCT02117934 · COMPLETED
Trial details
- NCT number
- NCT02117934
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-04-01
- Primary completion
- 2015-10-01
- Enrollment
- 8374
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.